Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2972108 | The Journal of Heart and Lung Transplantation | 2009 | 8 Pages |
Abstract
Centrifugal, axial, and pulsatile LVADs all provide adequate circulatory support to maintain appropriate end-organ function in patients with end-stage heart failure. The advantages of the newer continuous-flow devices can be safely applied to an increasing number of patients. Long-term studies (>1 year) are needed to assess effects on end-organ function with continuous-flow devices, which may have important implications for use as destination therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Forum MD, Andrew MD, Kenneth MD, Monica MD, Lyle MD, Ranjit MD,